Episode

Cancer's Clues: How Biomarkers are Changing the Game for Scientists

Podcast
The Persistence Lab
Published
Apr 16, 2026
Duration seconds
1171
Processing state
not_requested
Canonical source
https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html
Audio
https://pscrb.fm/rss/p/audio-delivery.cohostpodcasting.com/audio/e6f8ee87-47be-4a8e-a2cd-6c7f13dff165/episodes/5b0fd43c-f409-4b8e-be66-e9e0ae1621c2/episode.mp3
JSON
/v1/public/podcasts/the-persistence-lab-7666293/episodes/cancer-s-clues-how-biomarkers-are-changing-the-game-for-scientists
Markdown
/podcast/the-persistence-lab-7666293/cancer-s-clues-how-biomarkers-are-changing-the-game-for-scientists.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-persistence-lab-7666293/episodes/cancer-s-clues-how-biomarkers-are-changing-the-game-for-scientists/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-persistence-lab-7666293/cancer-s-clues-how-biomarkers-are-changing-the-game-for-scientists.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

For patients with tough-to-treat cancers, treatment approaches have advanced significantly over the past several decades. Scientists have made significant progress in understanding cancer biology. In this episode, sponsored by AbbVie, we explore how the discovery of biomarkers – the biological “signatures” for certain cancers – have helped create a paradigm shift in how we treat cancer by focusing on precision medicine approaches to target specific tumors. Not intended for UK audiences. To learn more about AbbVie’s research in oncology, visit:  https://www.abbvie.com/science/areas-of-focus/oncology.html .